First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial

R. Giampieri, M. Puzzoni, B. Daniele, D. Ferrari, S. Lonardi, A. Zaniboni, L. Cavanna, G. Rosati, N. Pella, M.G. Zampino, P. Sozzi, D. Germano, V. Zagonel, C. Codecà, M. Libertini, R. Labianca, S. Cascinu, M. Scartozzi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1099-1104
Number of pages6
JournalBritish Journal of Cancer
Issue number8
Publication statusPublished - 2017

Cite this